Catalysts for Celltrion Inc
29 tracked
Jan 21, 2026
approval
AVTOZMA (TOCILIZUMAB-ANOH) — FDA approval
AVTOZMA
→
Jan 14, 2026
approval
AVTOZMA (TOCILIZUMAB-ANOH) — FDA approval
AVTOZMA
→
Dec 12, 2025
approval
STEQEYMA (USTEKINUMAB-STBA) — FDA approval
STEQEYMA
→
Dec 1, 2025
approval
OMLYCLO (OMALIZUMAB-IGEC) — FDA approval
omalizumab biosimilar
→
Oct 29, 2025
approval
OSENVELT (DENOSUMAB-BMWO) — FDA approval
OSENVELT
→
Oct 16, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Oct 2, 2025
approval
EYDENZELT (AFLIBERCEPT-BOAV) — FDA approval
EYDENZELT
→
Sep 10, 2025
approval
OSENVELT (DENOSUMAB-BMWO) — FDA approval
OSENVELT
→
Jul 29, 2025
approval
AVTOZMA (TOCILIZUMAB-ANOH) — FDA approval
AVTOZMA
→
Jun 13, 2025
approval
STEQEYMA (USTEKINUMAB-STBA) — FDA approval
STEQEYMA
→
May 21, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
May 21, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Apr 30, 2025
approval
STEQEYMA (USTEKINUMAB-STBA) — FDA approval
STEQEYMA
→
Apr 28, 2025
approval
STEQEYMA (USTEKINUMAB-STBA) — FDA approval
STEQEYMA
→
Apr 7, 2025
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Mar 7, 2025
approval
OMLYCLO (OMALIZUMAB-IGEC) — FDA approval
omalizumab biosimilar
→
Feb 28, 2025
approval
OSENVELT (DENOSUMAB-BMWO) — FDA approval
OSENVELT
→
Jan 24, 2025
approval
AVTOZMA (TOCILIZUMAB-ANOH) — FDA approval
AVTOZMA
→
Dec 23, 2024
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 17, 2024
approval
STEQEYMA (USTEKINUMAB-STBA) — FDA approval
STEQEYMA
→
Aug 16, 2024
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 22, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 22, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Dec 22, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Nov 30, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Oct 2, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Sep 21, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
Sep 6, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→
May 23, 2023
approval
YUFLYMA (ADALIMUMAB-AATY) — FDA approval
YUFLYMA
→